BASF Articles
French Drug Firms Censured Over Promotions
12 August 1997
European And London Stock Comment
24 July 1997
Knoll Stake Hike In India "Will Be Costly"
18 July 1997
Stock Comment Europe
17 July 1997
Knoll To Make France Its Number Two Production Site
10 July 1997
Europe Stock Comment
30 May 1997
BASF/Knoll Faces Lawsuit In USA Over Synthroid
26 May 1997
Knoll Plans $37M Investment In Brazil
5 May 1997
European And London Stock Comment
21 April 1997
EUROPEAN AND LONDON STOCK COMMENT
10 April 1997
BASF Bullish On 1997 As Reflects On 1996
9 April 1997
Knoll And Boots Speed Up Portfolio Harmonization
7 April 1997
BASF Group Sales And Earnings Rise For 1996
26 March 1997
EUROPEAN AND LONDON STOCK COMMENT
26 March 1997
Appointment At BASF AG
26 March 1997
French Govt Launches Generics Decree
19 March 1997
EUROPEAN AND LONDON STOCK COMMENT
24 February 1997
Roche Enters New Product Phase With Bright Prospects
17 February 1997
Appointment At BASF Corp
3 February 1997
Knoll And IVAX JV Replaced With Licensing Deals
27 January 1997
EUROPEAN AND LONDON STOCK COMMENT
20 January 1997
Chiroscience Hopes Verapamil Isomer Could Cut Constipation
20 January 1997
BASF/Knoll Considering More Investment In India
20 January 1997
EUROPEAN AND LONDON STOCK COMMENT
13 January 1997
Acquisitions And Mergers Continue, Led By Novartis
6 January 1997
Appointments At BASF
6 January 1997
Intercardia Signs Agreement With BASF For Beta Blocker
6 January 1997
No Hidden Surprises From US FTC For Birth Of Novartis
6 January 1997
Continued Approval Of Blockbuster Products In '97?
23 December 1996
Stock Commentary: Europe
9 December 1996
Stock Spectrum
9 December 1996
German Drug Firms In Search For Biotech Partners
9 December 1996
EUROPEAN AND LONDON STOCK COMMENTS
2 December 1996
Slower Profits Growth At 9 Months For BASF
25 November 1996
EUROPEAN AND LONDON STOCK COMMENT
25 November 1996
EUROPEAN AND LONDON STOCK COMMENTS
18 November 1996
EUROPEAN AND LONDON STOCK COMMENT
4 November 1996
Protium UK Launch
4 November 1996
Biotech Joint Venture For BASF
4 November 1996
Sandoz, Knoll Buy Into Generics As Gehe Opts Out
21 October 1996
BASF Unit Holds 5.17% Stake In Ivax
21 October 1996
Sandoz To Sell Herbicide Unit To Progress Novartis Merger
14 October 1996
EUROPEAN STOCK COMMENT
7 October 1996
Knoll's Sibutramine Rejected By US Panel
7 October 1996
Europe Stock Comment
9 September 1996
EUROPEAN AND LONDON STOCK COMMENT
2 September 1996
Boots Buy Boosts BASF In 1996 First Half
2 September 1996
European And London Stock Comment
19 August 1996
Tokyo Stock Comment
19 August 1996
Ares-Serono To License Growth Hormone Product To BASF
12 August 1996
Chiroscience Gets First Product Approval
8 July 1996
Europe Stock Comment
8 July 1996
Knoll Receives UK Clearance For Pantoprazole
24 June 1996
Europe Stock Comment
10 June 1996
BASF Signs Cancer Deal With Mitotix
3 June 1996
BASF Acquires Drug Discovery Tool
20 May 1996
Sales Fall But Profit Up 27% At BASF
20 May 1996
Redux Approved In The USA; Launch In June
6 May 1996
TOKYO STOCK COMMENT
22 April 1996
Knoll Buys Hokuriku Stake
15 April 1996
Tokyo Stock Comment
15 April 1996
Tokyo Stock Comment
8 April 1996
BASF To Invest $500 Million In NAFTA
8 April 1996
BASF To Introduce 4 New Drugs In 1996-7
8 April 1996
Premarin Heads Top-10 Prescription Drugs
1 April 1996
BASF Strong In 1995 As Shapes Up For The Future
1 April 1996
EUROPE STOCK COMMENT
25 March 1996
Knoll Buying Majority Stake In Hokuriku Seiyaku
25 March 1996
Salbu-BASF Launched
18 March 1996
Profits At BASF Almost Double In 1995
18 March 1996
Knoll Appointments
11 March 1996
EUROPE STOCK COMMENT
11 March 1996
EUROPE STOCK COMMENT
4 March 1996
BASF-Knoll Seeks Pharma Research Partner
4 March 1996
Stock Comment - Europe
26 February 1996
BASF appointment
29 January 1996
BASF: SriLanka joint venture
29 January 1996
European Stock Markets Review 1995
22 January 1996
German Drug Firms Invest More But Cutting Jobs
8 January 1996
Major M&As in 1995 As UK Industry Consolidates
8 January 1996
European Stock Comment
27 November 1995
EUROPEAN STOCK COMMENT
13 November 1995
Boots Doubles BASF Sales In US Drug Market
13 November 1995
Ivax Nycomed, A Defensive Merger?
6 November 1995
European Stock Comment
30 October 1995
BASF AG raises yearly bonus
23 October 1995
Ciba's Nine-Months Sales Slowed by Currency Strength
16 October 1995
EUROPEAN STOCK COMMENT
2 October 1995
BASF Ready To Go For Ivax?
2 October 1995
Boots Goes For Self-Medication Market In France
2 October 1995
European Stock Comment
25 September 1995
BASF Says Jobs To Go At Former Boots Site
25 September 1995
European Stock Comment
4 September 1995
12% Earnings Rise For BASF In 1995 1st Half
4 September 1995
Knoll Files Sibutramine NDA In USA
21 August 1995
Knoll appointment
14 August 1995
Knoll appointments
10 July 1995
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
